Similar articles for PMID: 12621012

Year	Number of Results
1987	1
1988	2
1989	1
1990	2
1991	1
1992	4
1993	7
1994	3
1995	8
1996	10
1997	14
1998	15
1999	9
2000	14
2001	15
2002	13
2003	18
2004	6
2005	16
2006	10
2007	11
2008	7
2009	15
2010	8
2011	10
2012	4
2013	9
2014	10
2015	11
2016	7
2017	12
2018	12
2019	9
2020	10
2021	15
2022	7
2023	2
2024	0

1

Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

Subbiah K, Hamlin DK, Pagel JM, Wilbur DS, Meyer DL, Axworthy DB, Mallett RW, Theodore LJ, Stayton PS, Press OW. Subbiah K, et al. J Nucl Med. 2003 Mar;44(3):437-45. J Nucl Med. 2003. PMID: 12621012 Free article.

2

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.

Pagel JM, Hedin N, Subbiah K, Meyer D, Mallet R, Axworthy D, Theodore LJ, Wilbur DS, Matthews DC, Press OW. Pagel JM, et al. Blood. 2003 Mar 15;101(6):2340-8. doi: 10.1182/blood-2002-03-0874. Epub 2002 Nov 21. Blood. 2003. PMID: 12446461 Free article.

3

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts.

Press OW, Corcoran M, Subbiah K, Hamlin DK, Wilbur DS, Johnson T, Theodore L, Yau E, Mallett R, Meyer DL, Axworthy D. Press OW, et al. Blood. 2001 Oct 15;98(8):2535-43. doi: 10.1182/blood.v98.8.2535. Blood. 2001. PMID: 11588052 Free article.

4

Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.

Pagel JM, Lin Y, Hedin N, Pantelias A, Axworthy D, Stone D, Hamlin DK, Wilbur DS, Press OW. Pagel JM, et al. Blood. 2006 Jul 1;108(1):328-36. doi: 10.1182/blood-2005-11-4327. Epub 2006 Mar 23. Blood. 2006. PMID: 16556891 Free PMC article.

5

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.

Pagel JM, Orgun N, Hamlin DK, Wilbur DS, Gooley TA, Gopal AK, Park SI, Green DJ, Lin Y, Press OW. Pagel JM, et al. Blood. 2009 May 14;113(20):4903-13. doi: 10.1182/blood-2008-11-187401. Epub 2009 Jan 5. Blood. 2009. PMID: 19124831 Free PMC article.

6

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.

Frost SH, Frayo SL, Miller BW, Orozco JJ, Booth GC, Hylarides MD, Lin Y, Green DJ, Gopal AK, Pagel JM, Bäck TA, Fisher DR, Press OW. Frost SH, et al. PLoS One. 2015 Mar 18;10(3):e0120561. doi: 10.1371/journal.pone.0120561. eCollection 2015. PLoS One. 2015. PMID: 25785845 Free PMC article.

7

Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.

Yao Z, Zhang M, Axworthy DB, Wong KJ, Garmestani K, Park L, Park CW, Mallett RW, Theodore LJ, Yau EK, Waldmann TA, Brechbiel MW, Paik CH, Pastan I, Carrasquillo JA. Yao Z, et al. Cancer Res. 2002 Oct 15;62(20):5755-60. Cancer Res. 2002. PMID: 12384535

8

Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.

Sharkey RM, Karacay H, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Sharkey RM, et al. Cancer Res. 2008 Jul 1;68(13):5282-90. doi: 10.1158/0008-5472.CAN-08-0037. Cancer Res. 2008. PMID: 18593929 Free PMC article.

9

Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Park SI, Shenoi J, Frayo SM, Hamlin DK, Lin Y, Wilbur DS, Stayton PS, Orgun N, Hylarides M, Buchegger F, Kenoyer AL, Axtman A, Gopal AK, Green DJ, Pagel JM, Press OW. Park SI, et al. Clin Cancer Res. 2011 Dec 1;17(23):7373-82. doi: 10.1158/1078-0432.CCR-11-1204. Epub 2011 Oct 5. Clin Cancer Res. 2011. PMID: 21976541 Free PMC article.

10

In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.

Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ. Lewis MR, et al. J Nucl Med. 2003 Aug;44(8):1284-92. J Nucl Med. 2003. PMID: 12902420 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

308 results

Results by year